Frances Oldham Kelsey papers, 1890-2016 (Library of Congress Finding Aid)

Access restrictions apply.Some or all content stored offsite.

Container	Contents

	Part II: Subject File, 1902-2012 (continued)
BOX II:164			Research Involving Human Subjects Committee, 1983, 1989, 1999-2000, undated
BOX II:164			Seeding trials, 1987-1988
BOX II:164		International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use (ICH)
BOX II:164			1987-1990
				(5 folders)
BOX II:164			1991
				(2 folders)
BOX II:165				(1 folder)
BOX II:165			1992
				(4 folders)
BOX II:165			1993
BOX II:165				Jan.
BOX II:165				Feb.
					(2 folders)
BOX II:166					(2 folders)
BOX II:166				Mar.-Sept.
					(6 folders)
BOX II:167				Oct.-Nov.
					(3 folders)
BOX II:167			1994-1997, 2000-2001, undated
				(3 folders)
BOX II:167		International Research and Development Corp., 1978, 1986-1991, 1996-1999
			(1 folder)
BOX II:168			(1 folder)
BOX II:168		Investigational Drug Branch, U.S. Food and Drug Administration, 1960-1967, undated
BOX II:168		Investigational new drugs (INDs)
BOX II:168			Charges for, 1982-1987, 1995
BOX II:168			Differences in opinion during IND/New Drug Application processes, 1979
BOX II:168			IND cover sheet and BIMO data collection sheet, 1974-1979
				(2 folders)
BOX II:168			Miscellany, 1964-1965, 1996-1997
BOX II:168			Outline submitted to Goddard, 1967
BOX II:168			Revision of IND and NDA regulations, 1974
BOX II:168			Rewrite, 1984
BOX II:168		Isoniazid, 1960-1974, undated
BOX II:168		Jolly, Eugene Richard, 1958, 1975-1976, 1982-1986, 1998-1999, undated
BOX II:168		Kerlan, Irvin, 1958-1961, 1966, 1997, undated
BOX II:168		Krebiozen, 1953, 1962-1966, 1984, 1999
BOX II:169		Laetrile
BOX II:169			General, 1977-1982, 1997-2000
BOX II:169			Testimony of Kelsey, 1979
BOX II:169		Ley, Herbert L., questions for interview, 1967-circa 1968, 1998
BOX II:169		Librium and valium, 1960-1990, undated
			(2 folders)
BOX II:169		Lithium, 1966-1972, 1975-1986, undated
BOX II:169		Livingston lysate, 1969
BOX II:169		Lotronex (Alosetron), 2000-2002
BOX II:169		LSD (Drug), 1963, 1969-1971, 1977, 1996-1999
BOX II:169		Male role in fertility and birth defects, 1952, 1962-1972, 1978-1981, 1987-1989, 1998, undated
BOX II:169		Marine pharmacology, 1969-1991, 1998-2001, undated
BOX II:169		Marrazzi, Amedeo S., 1975-1976, 1999, undated
BOX II:170		Maternal-Child Problems Task Force See also Container II:100, Bendectin
BOX II:170			1979-1981
				(6 folders)
BOX II:170			1982
				(1 folder)
BOX II:171				(2 folders)
BOX II:171			1983, 1996, undated
				(3 folders)
BOX II:171		Memoranda of understanding
BOX II:171			Defense Department, investigational new drugs, 1969, 1974-1981, 1986-1987, 1997-1998
				(2 folders)
BOX II:171			General, 1971-1975, 1982-1988, 1998, undated
BOX II:171			National Institutes of Health, 1975-1981
BOX II:172			New York Department of Health, 1978-1979
BOX II:172			Veteran’s Administration, 1977-1984
BOX II:172		Mercury, 1968-1987, 1996, undated
BOX II:172		Methadone monitoring, 1971-1990, 1999, undated
			(5 folders)
BOX II:173		Methotrexate, 1948-1972, 1978, undated See also Container II:98, Antimetabolites/anticancer
			(3 folders)
BOX II:173		Methyl CCNU (Drug) See Containers II:180-II:182, National Cancer Institute
BOX II:173		Mifeprex (mifepristone), 2000
BOX II:173		Mintz, Morton, 1966, 1996
BOX II:173		Miscellany
BOX II:173			Chronological
BOX II:173				1961-1973
					(6 folders)
BOX II:174				1974-1979
					(8 folders)
BOX II:174				1980
					(1 folder)
BOX II:175					(1 folder)
BOX II:175				1981-1983
					(6 folders)
BOX II:176				1984-1994
					(11 folders)
BOX II:177				1995-2001
					(8 folders)
BOX II:178				2002, undated
					(2 folders)
BOX II:178				Fragments, undated
BOX II:178			Clippings
BOX II:178				1951-1999
					(6 folders)
BOX II:179				2000-2002, undated
					(4 folders)
BOX II:179				Fragments, 1955, 1966-1974, 1983-1986, 1997-2001
BOX II:179		Misconduct in science
BOX II:179			Public Health Service initiatives and procedures, 1983-1988
BOX II:179			Reports to the Office of Management and Systems, 1982-1983, 1997-1999
				(1 folder)
BOX II:180				(1 folder)
BOX II:180		Modell, Walter, 1959, 1967-1971, undated
BOX II:180		Monensin See Container II:139, Eli Lilly and Co. Task Group
BOX II:180		Monosodium glutamate (MSG), 1967-1973, 1996, undated
BOX II:180		Moulton, Barbara, 1963-1965, 1980, 1996-2000, undated
BOX II:180		Multivitamins, circa 1951, 1962-1963. 1972, 1980-2001
BOX II:180		National Cancer Institute
BOX II:180			1964-1980
				(3 folders)
BOX II:181			1981
				(6 folders)
BOX II:181			1982
				(1 folder)
BOX II:182				(1 folder)
BOX II:182			1983-1985, 1992-1997, undated
				(2 folders)
BOX II:182		National Center for Toxicological Research Protocol Task Force, 1966-1972, 2000
BOX II:182		National Institutes of Health
BOX II:182			National Institute of Mental Health
BOX II:182				Death of subject, 1980-1981, 1997-1999
BOX II:182				Principal Investigators of Early Clinical Drug Evaluation Units, meeting minutes, 1961-1962
BOX II:182			Perinatal study See Container II:196, Foundation for Medical Research Perinatal Study
BOX II:182			Representatives of the U.S. Food and Drug Administration on study sections, 1963-1965, undated
Next Page »

Frances Oldham Kelsey papers, 1890-2016

Contents List